With some careful research and a lump sum to invest, it’s possible for a Stocks and Shares ISA to grow rapidly. Indeed, there are five well-known FTSE 100 stocks that have delivered an average annual return of 10.7% since July 2021.
More importantly, could this performance be repeated over the next 12 months? Let’s take a closer look.
Who?
The five stocks in question — and the average annual growth rate in their share prices over the past five years — are:
- Coca-Cola HBC (LSE:CCH) – 13.8%
- Next – 12.7%
- AstraZeneca – 10.6%
- BP – 9%
- National Grid – 7.6%
Anyone investing £10,000 in these in July 2021 would now have a portfolio worth £16,740. And this excludes the dividends paid during this period.
I could have chosen stocks that have done even better. Instead, I’ve picked five famous names from different sectors. All of the companies in question have significant overseas operations, which helps spread risk across different territories.
Cheers!
Of course, there’s no guarantee a stock’s past performance will be repeated. But one of them – Coca-Cola HBC – has been growing for decades now. And I see no reason why this shouldn’t continue over the next 12 months and beyond.
The group has bottling rights in 29 markets across three continents. Significantly, 63% of its 2025 sales volumes came from emerging markets that are growing faster than more established territories.
Excitingly, it hopes to complete a $2.6bn deal by the end of 2026 to acquire 75% of Coca-Cola Beverages Africa. This will give it access to another 14 markets, which the group describes as having “extraordinary potential”.
In 2025, it reported earnings per share of €2.72. Analysts are expecting significant growth over the next five years:
- 2026 – €2.89
- 2027 – €3.18
- 2028 – €3.49
- 2029 – €3.89
- 2030 – €4.28
If the 2030 forecast can be achieved, it means the stock’s currently (12 July) trading on a modest 13.6 times earnings. Its five-year average (median) is 15.1.
The strongest, broadest, most flexible portfolio of brands in the industry with growth opportunities across high value occasions and categories
Coca-Cola HBC website
But like any business, the group faces some challenges. Competition in the sector is intense with lots of new brands trying to take market share.
And even though the group sells the world’s most popular drink, Coca-Cola, tastes could change rapidly. It’s believed that all varieties of the brand account for around half of The Coca-Cola Company’s worldwide sales. This could be a major problem if drinkers decide to go elsewhere.
However, Coca-Cola HBC continues to grow its revenue. In 2025, it increased 7.9% year-on-year. Free cash flow was an impressive €700m and net debt was only 0.7 times EBITDA (earnings before interest, tax, depreciation, and amortisation).
It also pays (no guarantees) a reasonable dividend.
A final thought
I’d have to do more research before deciding whether it would be a good idea to take a stake in all five companies on my list. But I think their five-year performances illustrate the potential benefits from long-term investing in quality stocks.
Indeed, I have taken a closer look at Coca-Cola HBC and, for the reasons outline above, have it in my Stocks and Shares ISA. I reckon others could consider adding some of the group’s shares to their own portfolios.
Should you invest £5,000 in Coca-Cola Hbc Ag right now?
When investing expert Mark Rogers and his team have a stock tip, it can pay to listen. After all, the flagship Twelfth Magpie Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.
And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Coca-Cola Hbc Ag made the list?
James Beard owns shares in Coca-Cola CCH plc and AstraZeneca plc.
